| Literature DB >> 19765563 |
Jia Zhao1, Ling Li, Chen Ling, Jie Li, Ji-Yan Pang, Yong-Cheng Lin, Jie Liu, Ruxun Huang, Guan-Lei Wang, Zhong Pei, Jinsheng Zeng.
Abstract
Xyloketal B is a novel marine compound with unique chemical structure isolated from mangrove fungus Xylaria sp. (no. 2508). Recently, we have demonstrated that Xyloketal B is an antioxidant and can protect against oxidized low density lipoprotein (LDL)-induced cell injury. In the present study, we investigated whether Xyloketal B can protect against ischemia-induced cell injury in an in vitro oxygen glucose deprivation (OGD) model of ischemic stroke in PC12 cells. We found that Xyloketal B could directly scavenge 1,1-diphenyl-2-picrylhydrazyl (DPPH) free radical and protect PC12 cells against OGD insult. Furthermore, Xyloketal B alleviated OGD-induced mitochondria superoxide, mitochondria fragmentation and GTPase dynamin-related protein 1 (Drp1) overexpression as well as reduction of mitochondrial membrane potential. All together, the present study demonstrates that Xyloketal B protects PC12 cells against OGD-induced cell injury and that the anti-oxidative property and protective action on mitochondria may account for its neuroprotective actions.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19765563 DOI: 10.1016/j.brainres.2009.09.034
Source DB: PubMed Journal: Brain Res ISSN: 0006-8993 Impact factor: 3.252